The 9-year-old Harborcreek Township girl used to run around with the other kids on the Rolling Ridge Elementary School ...

The Food and Drug Administration has rejected an application filed by Langhorne-based Savara for its new drug candidate ...

3 Congenital forms of the disease exist but are less understood ... To further explore the genetic basis of the sisters’ rare lung disease, Neehus and her collaborators recruited additional patients ...

Congenital lobar emphysema (CLE) is a rare lung malformation that occurs when air become trapped in the lungs. Infants with CLE have one or more lobes of the lung that are hyperinflated.

According to the Centers for Disease Control and Prevention (CDC ... Truncus arteriosus is a very rare congenital heart defect. It occurs when the main artery leaving the heart remains a single ...

Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases ... indicates that molgramostim may improve lung function, reduce disease burden, and decrease ...

Fibrodysplasia ossificans progressiva (FOP) is an extremely rare congenital condition that causes ... Affected populations: FOP is an extremely rare disease that is estimated to affect around ...

Karaleigh Landfried, 9, says that a rare lung disease leaves her constantly short of breath and unable to participate in ...

Veterans with a rare lung disease could have an easier time collecting Department of Veterans Affairs disability benefits under proposed changes announced by the agency Wednesday. The ailment ...

Of the 11 diagnoses, four were congenital adrenal hypoplasia, a rare disease that affects adrenal gland function and is caused by a gene located in a particularly difficult-to-access region of the ...

DENVER — A drug found in almost every medicine cabinet may be a treatment for a rare genetic disease ... No cure or treatment for the disease, called MAN1B1-congenital disorder of glycosylation ...

Savara (SVRA.O), opens new tab said on Wednesday its experimental therapy met the main goal of a late-stage trial by improving a measure of lung function in patients with a rare disease that ...